FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285726146> ?p ?o ?g. }

• W4285726146 abstract "Primary immunodeficiencies (PIDs), a heterogenous group of inborn errors of immunity, are predetermined at birth but may evolve with age, leading to a variable clinical and laboratory presentation. In contrast, secondary immunodeficiencies (SIDs) are acquired declines of immune cell counts and or/function. The most common type of SID is a decreased antibody level occurring as a consequence of extrinsic influences, such as an underlying condition or a side effect of some medications used to treat hematological malignancies and autoimmune disorders. Paradoxically, immune deficiencies initially attributed to secondary causes may partly be due to an underlying PID. Therefore, in the era of immune-modulating biologicals, distinguishing between primary and secondary antibody deficiencies is of great importance. It can be difficult to unravel the relationship between PID, SID and hematological malignancy or autoimmunity in the clinical setting. This review explores SID and PID crossovers and discusses challenges to diagnosis and treatment strategies. The case of an immunodeficient patient with follicular lymphoma treated with rituximab illustrates how SID in the setting of hematological cancer can mask an underlying PID, and highlights the importance of screening such patients. The risk of hematological cancer is increased in PID: for example, lymphomas in PID may be driven by infections such as Epstein-Barr virus, and germline mutations associated with PID are enriched among patients with diffuse large B-cell lymphoma. Clues suggesting an increased risk of hematological malignancy in patients with common variable immune deficiency (CVID) are provided, as well as pointers for distinguishing PID versus SID in lymphoma patients. Two cases of patients with autoimmune disorders illustrate how an apparent rituximab-induced antibody deficiency can be connected to an underlying PID. We highlight that PID is increasingly recognized among patients with autoimmune cytopenias, and provide guidance on how to identify PID and distinguish it from SID in such patients. Overall, healthcare professionals encountering patients with malignancy and/or autoimmunity who have post-treatment complications of antibody deficiencies or other immune abnormalities need to be aware of the possibility of PID or SID and how to differentiate them." @default.
• W4285726146 created "2022-07-18" @default.
• W4285726146 creator A5030709969 @default.
• W4285726146 creator A5037734477 @default.
• W4285726146 creator A5077220786 @default.
• W4285726146 date "2022-07-18" @default.
• W4285726146 modified "2023-10-18" @default.
• W4285726146 title "Secondary Immune Deficiency and Primary Immune Deficiency Crossovers: Hematological Malignancies and Autoimmune Diseases" @default.
• W4285726146 cites W1844353938 @default.
• W4285726146 cites W1984134914 @default.
• W4285726146 cites W1985508003 @default.
• W4285726146 cites W1995839977 @default.
• W4285726146 cites W2013176883 @default.
• W4285726146 cites W2035451300 @default.
• W4285726146 cites W2065558544 @default.
• W4285726146 cites W2097903760 @default.
• W4285726146 cites W2122203806 @default.
• W4285726146 cites W2142989775 @default.
• W4285726146 cites W2153936208 @default.
• W4285726146 cites W2163435798 @default.
• W4285726146 cites W2409831280 @default.
• W4285726146 cites W2415094030 @default.
• W4285726146 cites W2497324662 @default.
• W4285726146 cites W2559939203 @default.
• W4285726146 cites W2567426572 @default.
• W4285726146 cites W2586745005 @default.
• W4285726146 cites W2588916278 @default.
• W4285726146 cites W2597013228 @default.
• W4285726146 cites W2621980896 @default.
• W4285726146 cites W2729839477 @default.
• W4285726146 cites W2760838426 @default.
• W4285726146 cites W2792610506 @default.
• W4285726146 cites W2792648208 @default.
• W4285726146 cites W2792908940 @default.
• W4285726146 cites W2801254160 @default.
• W4285726146 cites W2801294878 @default.
• W4285726146 cites W2889912337 @default.
• W4285726146 cites W2902264758 @default.
• W4285726146 cites W2904100717 @default.
• W4285726146 cites W2911560980 @default.
• W4285726146 cites W2912809137 @default.
• W4285726146 cites W2913784281 @default.
• W4285726146 cites W2915680266 @default.
• W4285726146 cites W2927192868 @default.
• W4285726146 cites W2940433353 @default.
• W4285726146 cites W2948376322 @default.
• W4285726146 cites W2952514465 @default.
• W4285726146 cites W2954415000 @default.
• W4285726146 cites W2969776998 @default.
• W4285726146 cites W2971081730 @default.
• W4285726146 cites W2978952368 @default.
• W4285726146 cites W2985711157 @default.
• W4285726146 cites W2996944141 @default.
• W4285726146 cites W2998886612 @default.
• W4285726146 cites W3000301584 @default.
• W4285726146 cites W3010496793 @default.
• W4285726146 cites W3011648998 @default.
• W4285726146 cites W3107137762 @default.
• W4285726146 cites W3123894945 @default.
• W4285726146 cites W3154027397 @default.
• W4285726146 cites W3154547454 @default.
• W4285726146 cites W3156568885 @default.
• W4285726146 cites W3157944234 @default.
• W4285726146 cites W3159531940 @default.
• W4285726146 cites W3185236749 @default.
• W4285726146 cites W3195839423 @default.
• W4285726146 cites W4213231895 @default.
• W4285726146 doi "https://doi.org/10.3389/fimmu.2022.928062" @default.
• W4285726146 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35924244" @default.
• W4285726146 hasPublicationYear "2022" @default.
• W4285726146 type Work @default.
• W4285726146 citedByCount "12" @default.
• W4285726146 countsByYear W42857261462021 @default.
• W4285726146 countsByYear W42857261462022 @default.
• W4285726146 countsByYear W42857261462023 @default.
• W4285726146 crossrefType "journal-article" @default.
• W4285726146 hasAuthorship W4285726146A5030709969 @default.
• W4285726146 hasAuthorship W4285726146A5037734477 @default.
• W4285726146 hasAuthorship W4285726146A5077220786 @default.
• W4285726146 hasBestOaLocation W42857261461 @default.
• W4285726146 hasConcept C126322002 @default.
• W4285726146 hasConcept C159654299 @default.
• W4285726146 hasConcept C203014093 @default.
• W4285726146 hasConcept C2776433325 @default.
• W4285726146 hasConcept C2779019163 @default.
• W4285726146 hasConcept C2779338263 @default.
• W4285726146 hasConcept C2779399171 @default.
• W4285726146 hasConcept C2780194698 @default.
• W4285726146 hasConcept C2780653079 @default.
• W4285726146 hasConcept C71924100 @default.
• W4285726146 hasConcept C8891405 @default.
• W4285726146 hasConceptScore W4285726146C126322002 @default.
• W4285726146 hasConceptScore W4285726146C159654299 @default.
• W4285726146 hasConceptScore W4285726146C203014093 @default.
• W4285726146 hasConceptScore W4285726146C2776433325 @default.
• W4285726146 hasConceptScore W4285726146C2779019163 @default.
• W4285726146 hasConceptScore W4285726146C2779338263 @default.
• W4285726146 hasConceptScore W4285726146C2779399171 @default.
• W4285726146 hasConceptScore W4285726146C2780194698 @default.
• W4285726146 hasConceptScore W4285726146C2780653079 @default.

• next